On Friday, Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), lost - 7.05% to $103.28.
Vertex Pharmaceuticals Incorporated, declared that the European Union Committee for Medicinal Products for Human Use (CHMP) issued a positive Opinion recommending Marketing Authorization of ORKAMBI™ (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people ages 12 and older with two copies of the F508del mutation. In Europe, about 12,000 people with CF ages 12 and older have two copies of this mutation.
The CHMP also issued a positive Opinion recommending the indication of KALYDECO® (ivacaftor) be expanded to comprise children ages 2 to 5 with CF, in addition to the current approved use in people ages 6 and older, who have one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N and S549R). A new weight-based oral granule formulation of ivacaftor (50 mg and 75 mg) that is mixed in soft foods or liquids was created for these younger children. The CHMP Opinion for the use of ivacaftor in children ages 2 to 5 comprised a recommendation to extend weight-based dosing of ivacaftor to children ages 6 to 11 who weigh less than 25 kg using the new oral granule formulation. In addition, the CHMP issued a positive Opinion recommending ivacaftor for use in people with CF ages 18 and older who have the R117H mutation. In Europe, about 125 children ages 2 to 5 have one of the nine gating mutations comprised in recently’s positive Opinion, and about 250 adults have the R117H mutation.
“Recently’s recommendations bring us closer to being able to assist many more people with cystic fibrosis who presently do not have a medicine to treat the underlying cause of this chronic progressive disease,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical Officer at Vertex. “However, we know that there are many more people with CF who are still waiting for treatment, and we remain committed to ongoing to work toward our aim of creating new medicines for the vast majority of people with cystic fibrosis.”
Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs.
Shares of Monsanto Company (NYSE:MON), inclined 0.67% to $84.51, during its last trading session.
The Climate Corporation, a division of Monsanto Company (MON), declared at Farm Progress Show the launch of its newly integrated platform - bringing existing product offerings into one seamless platform and launching new solutions to turn farm data into real value for farmers. Climate’s existing suite of digital tools will become the Climate FieldView™ digital platform, and the company will launch new functionality over the course of the next few weeks for the 2016 season to further support data-driven decision making on the farm.
“For farmers, time and knowledge are the most valuable inputs,” said Mike Stern, President and Chief Operating Officer for The Climate Corporation. “The new Climate FieldView digital platform combines farmers’ field data with real-time and historic soil, crop and weather data to assist them efficiently manage their operations and gain deeper insights about their fields,” said Stern.
Monsanto Company, together with its auxiliaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, counting corn, soybean, cotton, and canola seeds principally under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds compriseing of tomato, pepper, melon, cucumber, pumpkin, squash, beans, broccoli, onions, lettuce, and other seeds under the Seminis and De Ruiter brands.
At the end of Friday’s trade, Shares of Paychex, Inc. (NASDAQ:PAYX), gained 0.76% to $46.69.
On September 29, 2015, the Paychex | IHS Small Business Jobs Index (SBJI) will expand its report on the state of small business employment growth by counting more data and analysis on hiring trends across the United States and industry sectors.
“Paychex pays one out of every 15 American private-sector employees, providing the opportunity to use real payroll data to gain insight into one of the main drivers of the U.S. economy – small businesses. Unlike other indicators that use survey data, our index harnesses possibly the largest small business dataset available to provide a valuable, leading indicator of change in small business employment growth,” said Martin Mucci, president and CEO of Paychex. “We’re looking forward to adding even greater value to the dialogue on the health of the U.S. economy with the addition of these new features.”
Paychex, Inc. provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany. The company offers payroll processing services that comprise the calculation, preparation, and delivery of employee payroll checks; production of internal accounting records and administration reports; preparation of federal, state, and local payroll tax returns; and collection and remittance of clients payroll obligations.
Finally, Capital One Financial Corp. (NYSE:COF), ended its last trade with 1.27% gain, and closed at $74.05.
Working Mother magazine, named Capital One as one of the 2015 Working Mother 100 Best Companies for its commitment to progressive workplace programs, counting advancement of women, flexibility, child care and paid parental leave. The 100 Best Companies are featured in the October/November issue of Working Mother and on workingmother.com.
“Capital One has worked to build an inclusive environment and family-friendly policies that support all of our associates,” said Lane Hopkins, Senior Vice President of Human Resources and Chief Diversity Officer. “We are committed to providing rewarding careers, benefits, and training, counting dedicated associate networks designed to foster an open and supportive work environment and enhance the overall experience for our associates in both their professional and personal lives. We are proud of the Capital One culture and what we’ve achieved and we are honored once again to be named to Working Mother Magazine’s Top 100 list.”
Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA); and Capital One, National Association (CONA), which provide various financial products and services in the United States, the United Kingdom, and Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
